| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 600 | $80 | $50.5K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 140 | $140 | $18.6K |
| 53854 | The provider uses a radiofrequency–generated water vapor thermal device to destroy prostate tissue to treat BPH and lower urinary tract symptoms. | 10 | $1,210 | $13.3K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 80 | $140 | $11.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 110 | $110 | $11.6K |
| 99222 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 110 | $90 | $10.3K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 150 | $60 | $8.9K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 20 | $280 | $6.6K |
| J9030 | BCG live intravesical instillation, 1 mg | 3,150 | $1 | $6.3K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 60 | $60 | $3.9K |